C vs SRTAW · P/E 16, rev $85.22B vs rev $248.7M
Citigroup Inc. (C) versus Strata Critical Medical, Inc. (SRTAW) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
C currently screens at market cap $214.73B and trailing P/E 15.5. SRTAW currently screens at market cap $0.
Not investment advice. Open the C and SRTAW stock pages for the full models.
Not investment advice.